Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Find out various ways to enhance your cash back while grocery shopping. Boost your savings effortlessly with these tips.
28,120 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Bitcoin remains in focus as investors weigh new geopolitical flare-ups. Markets are pricing risk as bitcoin (and peac...
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
When a high-profile couple asks guests not to bring gifts, it sparks a new angle on wedding budgeting. This article d...
A UK asset manager launches a native on-chain model for a regulated bond fund, aiming to record bond fund ownership r...
A leading bank projects XRP could reach $28 by 2030, even as Ripple pushes a new stablecoin. The forecast highlights ...
More Americans 65+ continue to work and fund HSAs, but Medicare Part A backdating can create excess contributions and...
A single ETF provides regulated exposure to U.S. cannabis operators by using swaps to bypass direct holdings. The tra...
In the wake of a $36 million breach, Humanity Protocol shifts from consumer crypto services to enterprise AI, led by ...
Ethereum trades near $1,780 as Vitalik Buterin outlines Lean Ethereum, a multi-year overhaul that could redefine data...
TTRF Capital Ltd quietly added a new stake in IREN Limited, buying 66,800 shares worth about $3.1 million. This shift...
The CLARITY Act failed to hit its July 4 milestone. With August 7 looming, Senate leadership faces a narrow window to...